Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001296549-26-000002

Options or other derivatives

  • Director acquired 1,192,946 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Belldegrun Arie Director 2026-02-02 Grant or award · Stock Option (Right to buy) +929,913 929,913 D: show line 1 in the form
Belldegrun Arie Director 2026-02-02 Grant or award · Restricted Stock Unit +263,033 263,033 D: show line 2 in the form
Loading xslF345X05/wk-form4_1770242650.xml…